Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.1T | 1.1T | 1.2T | 1.2T |
Cost of revenue | 382.1B | 416.9B | 394.3B | 387.0B |
Gross profit | 671.3B | 727.3B | 781.7B | 821.0B |
Operating expense | ||||
Research & development | 216.0B | 170.2B | 175.6B | 168.5B |
Selling general and admin | 295.9B | 270.6B | 268.3B | 270.0B |
Other operating expenses | -85.2B | 146.2B | -50.4B | 53.4B |
Operating income | 41.5B | -22.4B | 273.6B | 166.3B |
Non operating interest income | ||||
Income | -8.2B | -7.0B | 4.1B | 30.7B |
Expense | -22.4B | 31.6B | 68.5B | 59.7B |
Other income expense | -120.2B | 87.4B | -89.9B | -712M |
Pretax income | -107.3B | 26.4B | 119.4B | 136.6B |
Tax provision | -4.2B | 2.6B | 27.3B | 41.3B |
Net income | -103.1B | 23.8B | 92.1B | 95.3B |
Basic EPS | — | — | — | 60.7 |
Diluted EPS | — | — | — | 59.9 |
Basic average shares | — | — | — | 1.6B |
Diluted average shares | — | — | — | 1.6B |
EBITDA | 73.3B | 245.0B | 380.3B | 388.5B |
Net income from continuing op. | -103.1B | 23.8B | 92.1B | 95.3B |
Minority interests | -57M | -46M | -61M | -51M |
Preferred stock dividends | — | — | — | — |